![]() Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. | |||
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Stevenage, GB HQ London, GB Ambler, US | Locations Seattle, US HQ |
Employees | Employees 20 | Employees 502% increase | Employees 47 |
Funding | |||
Total funding raised | Total funding raised $ 225.5m | Total funding raised $ 205.7m | Total funding raised N/A |

Gyroscope Therapeutics Holdings is an ophthalmology company.
View companyVariant Bio is a biotechnology company that develops human genetic diversity therapies.
View company